A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
Clinical trial NCT04512066 · COMPLETED
Trial details
- NCT number
- NCT04512066
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-08
- Primary completion
- 2022-06-21
- Enrollment
- 287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.